184 related articles for article (PubMed ID: 32540399)
1. Impact of T-cell receptor and B-cell receptor repertoire on the recurrence of early stage lung adenocarcinoma.
Liu J; Yang X; Lu X; Zhang L; Luo W; Cheng Y; Zhang L; Yang Y; Dai N; Xu Y; Guan Y; Xiao H; Li M; Wang D
Exp Cell Res; 2020 Sep; 394(2):112134. PubMed ID: 32540399
[TBL] [Abstract][Full Text] [Related]
2. TCR repertoire intratumor heterogeneity of CD4
Zhang C; Ding H; Huang H; Palashati H; Miao Y; Xiong H; Lu Z
Int J Cancer; 2019 Feb; 144(4):818-827. PubMed ID: 30151844
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive investigation of T and B cell receptor repertoires in an MC38 tumor model following murine anti‑PD‑1 administration.
Zhang L; Wang IM; Solban N; Cristescu R; Zeng G; Long B
Mol Med Rep; 2020 Aug; 22(2):975-985. PubMed ID: 32468004
[TBL] [Abstract][Full Text] [Related]
4. Immune repertoire: A potential biomarker and therapeutic for hepatocellular carcinoma.
Han Y; Li H; Guan Y; Huang J
Cancer Lett; 2016 Sep; 379(2):206-12. PubMed ID: 26188280
[TBL] [Abstract][Full Text] [Related]
5. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
Zhang C; Huang H; Miao Y; Xiong H; Lu Z
J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
7. Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma.
Shima T; Shimoda M; Shigenobu T; Ohtsuka T; Nishimura T; Emoto K; Hayashi Y; Iwasaki T; Abe T; Asamura H; Kanai Y
Cancer Sci; 2020 Feb; 111(2):727-738. PubMed ID: 31821665
[TBL] [Abstract][Full Text] [Related]
8. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
9. Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer.
Yoneda K; Kuwata T; Kanayama M; Mori M; Kawanami T; Yatera K; Ohguri T; Hisaoka M; Nakayama T; Tanaka F
Br J Cancer; 2019 Sep; 121(6):490-496. PubMed ID: 31388183
[TBL] [Abstract][Full Text] [Related]
10. T cell receptor β-chain repertoire analysis of tumor-infiltrating lymphocytes in pancreatic cancer.
Cui C; Tian X; Wu J; Zhang C; Tan Q; Guan X; Dong B; Zhao M; Lu Z; Hao C
Cancer Sci; 2019 Jan; 110(1):61-71. PubMed ID: 30426614
[TBL] [Abstract][Full Text] [Related]
11. Survival of the fetus: fetal B and T cell receptor repertoire development.
Rechavi E; Somech R
Semin Immunopathol; 2017 Nov; 39(6):577-583. PubMed ID: 28466095
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer.
Mony JT; Schuchert MJ
Front Immunol; 2018; 9():2298. PubMed ID: 30374348
[No Abstract] [Full Text] [Related]
13. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer.
Teramoto K; Igarashi T; Kataoka Y; Ishida M; Hanaoka J; Sumimoto H; Daigo Y
Lung Cancer; 2019 Nov; 137():56-63. PubMed ID: 31546072
[TBL] [Abstract][Full Text] [Related]
14. Next generation sequencing reveals novel alterations in B-cell heavy chain receptor repertoires associated with acute-on-chronic liver failure.
Yan Q; Wang L; Lai L; Liu S; Chen H; Zhang J; Dai Y; Sui W
Int J Mol Med; 2019 Jan; 43(1):243-255. PubMed ID: 30365073
[TBL] [Abstract][Full Text] [Related]
15. Sequencing the peripheral blood B and T cell repertoire - Quantifying robustness and limitations.
Simon JS; Botero S; Simon SM
J Immunol Methods; 2018 Dec; 463():137-147. PubMed ID: 30312601
[TBL] [Abstract][Full Text] [Related]
16. B cell variable genes have evolved their codon usage to focus the targeted patterns of somatic mutation on the complementarity determining regions.
Saini J; Hershberg U
Mol Immunol; 2015 May; 65(1):157-67. PubMed ID: 25660968
[TBL] [Abstract][Full Text] [Related]
17. Immune Repertoire Profiling Reveals that Clonally Expanded B and T Cells Infiltrating Diseased Human Kidneys Can Also Be Tracked in Blood.
Weinberger J; Jimenez-Heredia R; Schaller S; Suessner S; Sunzenauer J; Reindl-Schwaighofer R; Weiss R; Winkler S; Gabriel C; Danzer M; Oberbauer R
PLoS One; 2015; 10(11):e0143125. PubMed ID: 26600245
[TBL] [Abstract][Full Text] [Related]
18. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
19. P2RX7B is a new theranostic marker for lung adenocarcinoma patients.
Benzaquen J; Dit Hreich SJ; Heeke S; Juhel T; Lalvee S; Bauwens S; Saccani S; Lenormand P; Hofman V; Butori M; Leroy S; Berthet JP; Marquette CH; Hofman P; Vouret-Craviari V
Theranostics; 2020; 10(24):10849-10860. PubMed ID: 33042257
[No Abstract] [Full Text] [Related]
20. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
